Tom Chiller
Biographic Data
| ID | 9076746 |
|---|---|
| NAME | Tom Chiller |
| GIVEN NAMES | Tom |
| FAMILY NAME | Chiller |
| SIGNATURE | CHILLER T |
| AFFILIATIONS | Waterborne Environmental (United States) |
| ORCID | 0000-0002-2251-8033 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Cost-effectiveness evaluation of routine histoplasmosis screening among people living with advanced HIV disease in Latin America and the Caribbean
Histoplasma antigen can be detected in people with advanced HIV disease (AHD), allowing for early and accurate diagnosis of histoplasmosis. The aim of this analysis was to assess the cost-effectiveness of routine histoplasmosis screening using antigen detection, among people with AHD. We developed a decision analytic model to evaluate Histoplasma antigen screening among people with AHD. The model estimated the costs, effectiveness, and cost-effec…
A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
As of 2018, cryptococcal antigen (CrAg) screening in patients with advanced human immunodeficiency virus (HIV) disease (AHD) was not routinely implemented in Nigeria despite being recommended in the national HIV treatment guidelines. Our aim was to determine the prevalence and risk factors for asymptomatic cryptococcal antigenemia in adult people living with HIV (PLHIV) in Nigeria to advocate for the implementation of routine CrAg screening. A de…
No prominent works on this page.
Cost-effectiveness evaluation of routine histoplasmosis screening among people living with advanced HIV disease in Latin America and the Caribbean
Histoplasma antigen can be detected in people with advanced HIV disease (AHD), allowing for early and accurate diagnosis of histoplasmosis. The aim of this analysis was to assess the cost-effectiveness of routine histoplasmosis screening using antigen detection, among people with AHD. We developed a decision analytic model to evaluate Histoplasma antigen screening among people with AHD. The model estimated the costs, effectiveness, and cost-effec…
A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
As of 2018, cryptococcal antigen (CrAg) screening in patients with advanced human immunodeficiency virus (HIV) disease (AHD) was not routinely implemented in Nigeria despite being recommended in the national HIV treatment guidelines. Our aim was to determine the prevalence and risk factors for asymptomatic cryptococcal antigenemia in adult people living with HIV (PLHIV) in Nigeria to advocate for the implementation of routine CrAg screening. A de…
Antifungal resistance and susceptibility (2 works) · Disease (2 works) · Fungal Infections and Studies (2 works) · Immunology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Asymptomatic (1 work) · Cost effectiveness (1 work) · Cost-effectiveness analysis (1 work) · Cross-sectional study (1 work)